EnviroChemie builds modular wastewater oxidation plants
Press Release | EnviroChemie GmbH
APRIL 05, 2017
Rossdorf, Germany: – Water treatment specialist EnviroChemie has won a commission from a German-based pharma manufacturer to provide an Envochem® oxidation plant for treating production process wastewater. The new plant will be based on EnviroChemie’s modular concept, EnviModul.
Envochem: total oxidation
The EnviroChemie-developed Envochem oxidation reactor solution uses hydrogen peroxide and UV radiation to treat partial flows of problematic wastewater isolated from selected production processes. This oxidation ensures targeted and efficient neutralization of active pharmaceutical ingredients and substances that are hazardous to humans, animals and the environment. The pre-treated water is then returned to remaining wastewater for indirect discharge.
The client company selected the EnviModul design and construction concept as the modular wastewater treatment will be easier to adapt and upgrade, allowing the company to deal more swiftly and flexibly with future expansion needs or production process changes.
This latest commission comes shortly after EnviroChemie won a commission from a Slovenia-based pharmaceutical manufacturer to supply a similar modular Envochem oxidation plant – now under construction at the client’s production facility in Croatia.
Both modular wastewater treatment plants are being almost entirely pre-assembled under rigorously quality controlled conditions at EnviroChemie’s Rossdorf site near Darmstadt, minimizing the level of installation work required at the customer sites.
EnviroChemie GmbH has established a reputation over four decades for reliable and innovative technology for water and wastewater treatment, specializing in developing and implementing customized solutions for customers in the pharmaceutical industry and life sciences.
This ISO-9001, ISO 14001, ISO 50001 and OHSAS 18001 certified engineering company was founded in 1976 and offers a holistic range of “Made in Germany” branded products and services based on chemico-physical, biological and membrane filtration processes, whose pedigree relies on its long list of research achievements and patents.
EnviroChemie adopts a partnership approach in which client specialized needs and characteristics form the basis for individual design, planning, engineering, building and commissioning of pharmaceutical wastewater treatment plants.
With more than 30,000 plants sold worldwide, EnviroChemie can apply unrivalled experience to continuous development of innovative and reliable industrial water and wastewater technologies.
EnviroChemie specializes in supporting customers in projects, where effluents must be specifically treated to:
- Abate trace elements by concentrating them (e.g. reverse osmosis and vacuum distillation)
- Inactivate streams containing biologically active ingredients (e.g. vaccines, antigens, etc.) by means of thermal sterilization technology
- Eliminate pharmaceuticals implementing advanced oxidation processes (e.g. ozonation)
- Generate green energy (biogas) from digested organic matter (COD) implementing
anaerobic treatment technology (e.g. at insulin production facilities)
EnviroChemie products are developed and supplied from three sites in Germany and Switzerland and the company operates seven sales and service offices, including subsidiaries in Brazil and Russia.
Jutta Quaiser, Press & PR Manager, EnviroChemie GmbH
Tel: +49 (0) 6154 6998 72
Click on EnviroChemie builds modular wastewater oxidation plants for other information.
Click on EnviroChemie to contact the company directly.